Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you consider eliminating post lumpectomy RT in a premenopausal patient with pCR after chemotherapy for a cT1cN0 triple negative breast cancer?
Answer from: Radiation Oncologist at Community Practice
We don't have any prospective data on omitting RT in this case and would not consider this approach for triple negative patients.
Sign In
or
Register
to read more
12900
Related Questions
Would you consider APBI in a patient who meets all criteria but has high-risk genomic testing and is not receiving chemotherapy?
How do you advise women to manage wound care for breast brachytherapy needle sites for long term cosmetic outcomes?
Is it appropriate to consider ultra-hypofractionation for phyllodes tumors of the breast when adjuvant radiotherapy is indicated?
Would you recommend post mastectomy radiation for a low grade adenoid cystic carcinoma of the breast resected with negative margins?
In what patients is it inappropriate to offer DCISionRT testing?
Would you offer partial breast irradiation for a patient who otherwise meets PBI guidelines but has a PTEN mutation?
What radiation fields would you recommend in a young patient with luminal B histology and ITCs in a single sentinel node?
How do you manage a symptomatic primary breast tumor in a patient with metastatic disease?
Does a high genomic risk score impact your radiation fields for patients with breast cancer?
What dose of reirradiation would you consider for locally recurrent breast cancer after mastectomy, excised with positive margins?